vs

Side-by-side financial comparison of Mastech Digital, Inc. (MHH) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $45.5M, roughly 1.8× Mastech Digital, Inc.). Mastech Digital, Inc. runs the higher net margin — 2.1% vs -38.1%, a 40.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -10.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -1.5%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

MHH vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.8× larger
PRCT
$83.1M
$45.5M
MHH
Growing faster (revenue YoY)
PRCT
PRCT
+30.6% gap
PRCT
20.2%
-10.4%
MHH
Higher net margin
MHH
MHH
40.2% more per $
MHH
2.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-1.5%
MHH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MHH
MHH
PRCT
PRCT
Revenue
$45.5M
$83.1M
Net Profit
$972.0K
$-31.6M
Gross Margin
28.3%
64.9%
Operating Margin
2.2%
-4.1%
Net Margin
2.1%
-38.1%
Revenue YoY
-10.4%
20.2%
Net Profit YoY
227.3%
-27.9%
EPS (diluted)
$0.08
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MHH
MHH
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$45.5M
$76.4M
Q3 25
$48.5M
$83.3M
Q2 25
$49.1M
$79.2M
Q1 25
$48.3M
$69.2M
Q4 24
$50.7M
$68.2M
Q3 24
$51.8M
$58.4M
Q2 24
$49.5M
$53.4M
Net Profit
MHH
MHH
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$972.0K
$-29.8M
Q3 25
$941.0K
$-21.4M
Q2 25
$135.0K
$-19.6M
Q1 25
$-1.4M
$-24.7M
Q4 24
$297.0K
$-18.9M
Q3 24
$1.9M
$-21.0M
Q2 24
$1.4M
$-25.6M
Gross Margin
MHH
MHH
PRCT
PRCT
Q1 26
64.9%
Q4 25
28.3%
60.6%
Q3 25
27.8%
64.8%
Q2 25
28.1%
65.4%
Q1 25
26.7%
63.9%
Q4 24
29.0%
64.0%
Q3 24
28.5%
63.2%
Q2 24
28.2%
59.0%
Operating Margin
MHH
MHH
PRCT
PRCT
Q1 26
-4.1%
Q4 25
2.2%
-40.6%
Q3 25
1.7%
-27.8%
Q2 25
0.1%
-28.0%
Q1 25
-3.8%
-39.7%
Q4 24
0.1%
-28.9%
Q3 24
4.7%
-38.4%
Q2 24
3.4%
-50.3%
Net Margin
MHH
MHH
PRCT
PRCT
Q1 26
-38.1%
Q4 25
2.1%
-39.1%
Q3 25
1.9%
-25.7%
Q2 25
0.3%
-24.7%
Q1 25
-3.0%
-35.8%
Q4 24
0.6%
-27.6%
Q3 24
3.6%
-35.9%
Q2 24
2.8%
-48.0%
EPS (diluted)
MHH
MHH
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.08
$-0.54
Q3 25
$0.08
$-0.38
Q2 25
$0.01
$-0.35
Q1 25
$-0.12
$-0.45
Q4 24
$0.01
$-0.34
Q3 24
$0.16
$-0.40
Q2 24
$0.12
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MHH
MHH
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$36.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$89.3M
$347.7M
Total Assets
$111.8M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MHH
MHH
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$36.5M
$286.5M
Q3 25
$32.7M
$294.3M
Q2 25
$27.9M
$302.7M
Q1 25
$24.7M
$316.2M
Q4 24
$27.7M
$333.7M
Q3 24
$23.9M
$196.8M
Q2 24
$20.6M
$214.1M
Total Debt
MHH
MHH
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
MHH
MHH
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$89.3M
$365.9M
Q3 25
$88.0M
$380.3M
Q2 25
$87.8M
$385.8M
Q1 25
$86.9M
$389.2M
Q4 24
$87.4M
$402.2M
Q3 24
$86.5M
$241.2M
Q2 24
$84.0M
$251.8M
Total Assets
MHH
MHH
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$111.8M
$508.1M
Q3 25
$112.6M
$511.5M
Q2 25
$110.4M
$513.1M
Q1 25
$110.1M
$519.4M
Q4 24
$111.5M
$534.0M
Q3 24
$111.5M
$374.1M
Q2 24
$107.5M
$374.4M
Debt / Equity
MHH
MHH
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MHH
MHH
PRCT
PRCT
Operating Cash FlowLast quarter
$4.4M
Free Cash FlowOCF − Capex
$4.3M
FCF MarginFCF / Revenue
9.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
4.48×
TTM Free Cash FlowTrailing 4 quarters
$10.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MHH
MHH
PRCT
PRCT
Q1 26
Q4 25
$4.4M
$-10.3M
Q3 25
$6.5M
$-6.6M
Q2 25
$3.3M
$-15.0M
Q1 25
$-3.0M
$-17.0M
Q4 24
$4.0M
$-32.4M
Q3 24
$3.3M
$-18.8M
Q2 24
$1.2M
$-15.7M
Free Cash Flow
MHH
MHH
PRCT
PRCT
Q1 26
Q4 25
$4.3M
$-12.2M
Q3 25
$6.3M
$-9.5M
Q2 25
$3.2M
$-17.8M
Q1 25
$-3.1M
$-18.8M
Q4 24
$3.9M
$-33.6M
Q3 24
$3.2M
$-19.0M
Q2 24
$707.0K
$-16.8M
FCF Margin
MHH
MHH
PRCT
PRCT
Q1 26
Q4 25
9.5%
-15.9%
Q3 25
13.0%
-11.4%
Q2 25
6.6%
-22.5%
Q1 25
-6.4%
-27.2%
Q4 24
7.7%
-49.2%
Q3 24
6.2%
-32.6%
Q2 24
1.4%
-31.4%
Capex Intensity
MHH
MHH
PRCT
PRCT
Q1 26
Q4 25
0.1%
2.4%
Q3 25
0.4%
3.4%
Q2 25
0.1%
3.5%
Q1 25
0.2%
2.7%
Q4 24
0.2%
1.7%
Q3 24
0.1%
0.4%
Q2 24
1.0%
2.0%
Cash Conversion
MHH
MHH
PRCT
PRCT
Q1 26
Q4 25
4.48×
Q3 25
6.88×
Q2 25
24.41×
Q1 25
Q4 24
13.60×
Q3 24
1.76×
Q2 24
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MHH
MHH

IT Staffing Services$37.6M83%
Data And Analytics Services$7.8M17%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons